Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.

Veldt BJ, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, Zeuzem S, Manns MP, Hansen BE, Schalm SW, Janssen HL.

Ann Intern Med. 2007 Nov 20;147(10):677-84.

PMID:
18025443
2.

Treatment of chronic hepatitis C in Asia: when East meets West.

Yu ML, Chuang WL.

J Gastroenterol Hepatol. 2009 Mar;24(3):336-45. doi: 10.1111/j.1440-1746.2009.05789.x. Review.

PMID:
19335784
3.

[Hepatitis C].

Moradpour D, Blum HE.

Ther Umsch. 2004 Aug;61(8):493-8. Review. German.

PMID:
15457965
4.

Treatment of interferon-alpha for chronic hepatitis C.

Moriyama M, Arakawa Y.

Expert Opin Pharmacother. 2006 Jun;7(9):1163-79. Review.

PMID:
16732703
5.

[Chronic hepatitis C].

Grammatikos G, Sarrazin C.

Dtsch Med Wochenschr. 2010 Dec;135(50):2525-34; quiz 2535-8. doi: 10.1055/s-0030-1269423. Epub 2010 Dec 7. Review. German.

PMID:
21140330
6.

Treatment considerations in patients with hepatitis C and cirrhosis.

Heathcote EJ.

J Clin Gastroenterol. 2003 Nov-Dec;37(5):395-8. Review.

PMID:
14564187
7.
8.

[Clinical characterization and peculiarities of the clinical course of low-activity hepatitis C].

Karpov SIu, Krel' PE.

Klin Med (Mosk). 2005;83(1):14-9. Review. Russian. No abstract available.

PMID:
15759484
9.

Virologic Cure of Hepatitis C: Impact on Hepatic Fibrosis and Patient Outcomes.

Gonzalez HC, Duarte-Rojo A.

Curr Gastroenterol Rep. 2016 Jul;18(7):32. doi: 10.1007/s11894-016-0508-y. Review.

PMID:
27177638
10.
11.

Chronic viral hepatitis: epidemiology, molecular biology, and antiviral therapy.

Gonzalez SA, Keeffe EB.

Front Biosci (Landmark Ed). 2011 Jan 1;16:225-50. Review.

PMID:
21196168
12.

Effect of interferon therapy on the natural history of hepatitis C virus-related cirrhosis and hepatocellular carcinoma.

Poynard T, Moussalli J, Ratziu V, Regimbeau C, Opolon P.

Clin Liver Dis. 1999 Nov;3(4):869-81. Review.

PMID:
11291256
13.

Management of end-stage liver disease in chronic hepatitis B.

Tan HH, Martin P.

Clin Liver Dis. 2010 Aug;14(3):477-93. doi: 10.1016/j.cld.2010.05.006. Review.

PMID:
20638026
14.

After the cure: management of HCV after achievement of SVR.

Zator ZA, Chung RT.

Curr HIV/AIDS Rep. 2013 Dec;10(4):428-35. doi: 10.1007/s11904-013-0181-9. Review.

PMID:
24218111
15.

Reversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C?

Lee YA, Friedman SL.

Antiviral Res. 2014 Jul;107:23-30. doi: 10.1016/j.antiviral.2014.03.012. Epub 2014 Apr 12. Review.

16.

Role of assessing liver fibrosis in management of chronic hepatitis C virus infection.

Carmona I, Cordero P, Ampuero J, Rojas A, Romero-Gómez M.

Clin Microbiol Infect. 2016 Oct;22(10):839-845. doi: 10.1016/j.cmi.2016.09.017. Epub 2016 Sep 24. Review.

17.

Management of Advanced Fibrosis in the Context of Hepatitis C Virus Infection.

Verna EC.

Top Antivir Med. 2017 Feb/Mar;25(1):7-11. Review.

18.

Interferon alpha in the treatment of chronic hepatitis C in children: a meta-analysis [correction of metanalysis].

Di Ciommo V, Russo P, Ravà L, Caprino L.

J Viral Hepat. 2003 May;10(3):210-4. Review.

PMID:
12753340
19.

Pleiotropic effects of statins in the diseases of the liver.

Janicko M, Drazilova S, Pella D, Fedacko J, Jarcuska P.

World J Gastroenterol. 2016 Jul 21;22(27):6201-13. doi: 10.3748/wjg.v22.i27.6201. Review.

20.

Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response.

Simmons B, Saleem J, Heath K, Cooke GS, Hill A.

Clin Infect Dis. 2015 Sep 1;61(5):730-40. doi: 10.1093/cid/civ396. Epub 2015 May 17. Review.

Supplemental Content

Support Center